This FTSE 100 stock can help you profit from an ageing population

Bilaal Mohamed sees an increase in demand for this FTSE 100 (INDEXFTSE:UKX) company’s products.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

It’s official – we’re all getting older! But before you go ahead and accuse me of stating the obvious, let me explain what I REALLY mean. You may have heard on many occasions the old saying about the only certainty in life being death (and taxes), but it seems that on average we’re all living longer, and the population on the whole is getting older, much older.

Motability scooters

This is particularly true in developed countries where a combination of better healthcare and fewer children is leading to an older population overall. Here in the UK, it’s estimated that around one in six people are currently over the age of 65, but that’s about to change. Forecasters say this figure is likely to be around one in four by 2050 – just imagine a quarter of the UK population armed with Motability scooters and Zimmer frames.

But seriously, how can we as investors profit from having such foresight? Well, let’s get the obvious one out of the way first, that is pharmaceuticals. Companies like GlaxoSmithKline and AstraZeneca are almost certain to benefit, not just here in the UK, but also in other developed nations, and in particular countries like Japan and Germany, were the general population trend is skewing older at an even faster rate than our own.

$4.7bn in sales

Diseases such as cancer and diabetes are sadly on the rise, and the increase in demand for a whole host of treatments should also benefit some of the smaller, more specialised drug companies. Perhaps less obvious to investors is the increase in demand for products and services supplied by firms such as Smith & Nephew (LSE: SN), best known as a world leader in joint replacement systems for knees, hips and shoulders.

But the FTSE 100 medical technology giant contributes a whole lot more than just orthopaedic reconstruction, with other facets of the business providing advanced wound management, sports medicine and trauma implant systems. With annual sales reaching almost $4.7bn last year, and a presence in more than 100 countries, Smith & Nephew is easily the largest medical technology business listed on the London Stock Exchange, and in my view still the best.

Greying population

And it’s not just ageing populations in developed markets that should help to swell demand for the company’s products in the future. Healthcare systems and hospital infrastructure in the developing world is improving at a considerable pace which, allied with improving incomes, should also help the group’s sales over the longer term.

Given the business’s defensive qualities and track record of steady growth, it’s perhaps not surprising that the share price has followed an upward trajectory since the company went public at the start of the millennium. However, a recent sell-off means the shares are available at a significant discount to last year’s all-time highs of 1,431p (trading at 1,264p late Friday afternoon). I believe anyone looking to profit from a greying population should seriously consider Smith & Nephew right now.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Bilaal Mohamed has no position in any shares mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. The Motley Fool UK has recommended AstraZeneca. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young mixed-race woman jumping for joy in a park with confetti falling around her
Investing Articles

6.9% dividend yield! 2 cheap stocks to consider for a £1,380 passive income

Looking for a market-beating passive income? These FTSE 100 and FTSE 250 dividend stocks could provide a healthy second income…

Read more »

Mature black couple enjoying shopping together in UK high street
Investing Articles

Potentially 34% undervalued, should I be watching the boohoo share price?

The boohoo share price has seen a rocky few years, but with signs that the economy is improving, could this…

Read more »

Investing Articles

Is the Amazon share price primed for a drop?

The Amazon share price has been on a tear for the last year, but can this trend continue? Gordon Best…

Read more »

Photo of a man going through financial problems
Investing Articles

Down 15% in a week! What’s gone wrong with the National Grid share price?

The National Grid share price isn't supposed to crash but now it has. Harvey Jones is wondering whether to take…

Read more »

Group of young friends toasting each other with beers in a pub
Investing Articles

Taylor Wimpey just paid me £158.78. I’m aiming to turn that into a £100k yearly second income

Harvey Jones says small, regular dividend payments can turn a few pounds into a mighty second income, if he gives…

Read more »

A pastel colored growing graph with rising rocket.
Value Shares

These FTSE 250 shares are tipped to rise 14% to 18% in the next year!

Looking for the best FTSE 250 momentum shares to buy? Here are two that City analysts expect to soar in…

Read more »

Young mixed-race woman jumping for joy in a park with confetti falling around her
Investing Articles

Lloyds’ share price is up 20% in 3 months! How high can it go?

Lloyds’ share price has ripped higher recently. Here, Edward Sheldon provides his view on the level it could potentially climb…

Read more »

Investing Articles

Why the Rolls-Royce share price could continue to outperform

The Rolls-Royce share price keeps moving forward, but this Fool thinks it's still behind where it ought to be after…

Read more »